NCT02219113View on ClinicalTrials.gov

Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
Knee Joint Osteoarthritis
Interventions
PROCEDURE

Arthroscopic surgery

PROCEDURE

Liposuction

DEVICE

ADRC isolation

ADRC isolation performed using Celution 800/CRS System (Cytori Therapeutics Inc) according to manufacturer's protocol

OTHER

Intraarticular administration of autologous ADRC

Trial Locations (1)

121359

"Federal State Budgetary Institution Central Clinical Hospital with Outpatient Health Center of the Business Administration for the President of the Russian Federation; Center for Biomedical Technologies", Moscow

All Listed Sponsors
collaborator

I.M. Sechenov First Moscow State Medical University

OTHER

lead

Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation

OTHER_GOV

NCT02219113 - Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage | Biotech Hunter | Biotech Hunter